Rocky Mountain Cancer Center, LLP — Boulder, Colorado

Rocky Mountain Cancer Center, LLP is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center, LLP has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non Small Cell Lung Cancer, KRAS Activating Mutation.

Sponsors: Verastem, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center, LLP?

Rocky Mountain Cancer Center, LLP has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center, LLP conducted?

Rocky Mountain Cancer Center, LLP has 1 clinical trials on record, with 1 currently active. Their work covers Non Small Cell Lung Cancer, KRAS Activating Mutation.

Is Rocky Mountain Cancer Center, LLP accredited by Crixeo Health?

Rocky Mountain Cancer Center, LLP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Center, LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.